CX Institutional Has $7.29 Million Stake in Colgate-Palmolive Company $CL

03 May 2026, 05:37 by Jessica Moore · The Cerbat Gem

CX Institutional raised its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 21.0% during the fourth quarter, Holdings Channel reports. The firm owned 92,262 shares of the company’s stock after purchasing an additional 15,983 shares during the period. CX Institutional’s holdings in Colgate-Palmolive were worth $7,291,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CL. Maseco LLP acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $27,000. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $29,000. Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $30,000. Global Wealth Strategies & Associates lifted its position in shares of Colgate-Palmolive by 300.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares during the period. Finally, Grove Bank & Trust lifted its position in shares of Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This trade represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $87.15 on Friday. The firm has a market capitalization of $69.92 billion, a PE ratio of 33.91, a price-to-earnings-growth ratio of 4.46 and a beta of 0.31. The firm has a fifty day simple moving average of $87.95 and a two-hundred day simple moving average of $84.11. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 EPS. Analysts forecast that Colgate-Palmolive Company will post 3.85 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 80.92%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CL shares. The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday. Bank of America dropped their target price on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their target price for the company from $90.00 to $98.00 in a research report on Monday, March 30th. Jefferies Financial Group boosted their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $100.00 to $95.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. Twelve equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $95.56.

Read Our Latest Research Report on Colgate-Palmolive

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

Positive Sentiment: Q1 top‑ and bottom‑line beat — Colgate reported EPS of $0.97 vs. $0.95 consensus and revenue of $5.32B (up 8.4% YoY), driven by pricing and volume growth; organic sales rose and base business EPS increased. Colgate Q1 Earnings & Sales Beat Estimates on Pricing & Volume Growth
Positive Sentiment: Strong international demand for core oral and personal care boosted results and topline momentum, a cited driver behind the beat. Colgate‑Palmolive beats Q1 estimates on strong international demand
Positive Sentiment: Board expands strategic growth & restructuring program — management is accelerating a multi‑year program (approved July 2025) intended to drive growth and cost savings, which supports margin recovery expectations. Colgate‑Palmolive Expands Strategic Growth and Restructuring Program
Neutral Sentiment: Management commentary and slides — the earnings call and slide deck provide detail on region‑level trends, pricing versus volume dynamics, and the timing of savings from the restructuring program. Review the transcript/slides for forward commentary. Colgate‑Palmolive Q1 2026 Earnings Call Transcript
Neutral Sentiment: Analysts updated forecasts ahead of and after the print — some revisions were already in place heading into the quarter; keep an eye on any further changes to price targets or model assumptions. Colgate‑Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Negative Sentiment: Margin pressure and one‑time/SGPP charges — GAAP EPS fell YoY (to $0.80) and gross profit margin slipped ~20 bps; management flagged costs and restructuring/SGPP charges that weighed on margins this quarter. These items are a watch point for near‑term profitability until savings materialize. Colgate Announces 1st Quarter 2026 Results

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.